Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for AbbVie
Company Monitoring Page for AbbVie
latest headlines for company on cafepharma
7 companies are rolling out Humira biosimilars
Drugstore News
Wed, 07/12/23 - 09:44 am
Tags:
AbbVie
,
Humira
,
biosimilars
,
Boehringer Ingelheim
,
Organon
,
Samsung Bioepsis
,
Sandoz
,
Fresenius Kabi
,
Celltrion
,
Coherus Biosciences
,
Biocon
Mark Cuban's online pharmacy set to launch Humira biosimilar
Reuters
Fri, 07/7/23 - 06:53 am
Tags:
biosimilars
,
Mark Cuban
,
Mark Cuban Cost Plus Drugs
,
AbbVie
,
Humira
,
Coherus Biosciences
Revance wants you to 'Break Up With Botox' as it goes to war with AbbVie in new anti-wrinkle market battle
Fierce Pharma
Mon, 07/3/23 - 10:44 am
Tags:
Revance Therapeutics
,
Daxxify
,
pharma marketing
,
AbbVie
,
Botox
Alvotech to raise cash after third FDA rejection for Humira biosimilar
BioPharma Dive
Fri, 06/30/23 - 11:39 am
Tags:
Alvotech
,
Teva Pharmaceutical
,
AbbVie
,
Humira
,
biosimilars
,
FDA
AbbVie, Genmab Bi-Specific Lymphoma Data Tee Up Potential Challenge to Roche Drug
BioSpace
Thu, 06/29/23 - 11:15 pm
Tags:
AbbVie
,
Genmab
,
Roche
,
follicular lymphoma
,
bispecific antibodies
,
epcoritamab
,
Lunsumio
Genmab and AbbVie plan next steps for Epkinly in follicular lymphoma
Clinical Trials Arena
Wed, 06/28/23 - 10:27 am
Tags:
AbbVie
,
Genmab
,
Epkinly
,
clinical trials
,
relapsed or refractory follicular lymphoma
What Will AbbVie Buy Next?
Motley Fool
Wed, 06/28/23 - 10:01 am
Tags:
AbbVie
,
M&A
,
Blueprint Medicines
,
Krystal Biotech
AbbVie's Imbruvica-Brukinsa patent suit may have merit, and BeiGene will likely settle: expert
Fierce Pharma
Tue, 06/27/23 - 10:21 pm
Tags:
AbbVie
,
patents
,
BeiGene
,
legal
,
Btk inhibitors
AbbVie's Skyrizi posts ulcerative colitis win in maintenance study, teeing up FDA nod
Fierce Pharma
Fri, 06/16/23 - 10:12 am
Tags:
AbbVie
,
ulcerative colitis
,
Skyrizi
,
FDA
AbbVie sues BeiGene over brand-new Imbruvica patent as blood cancer rivalry heats up
Fierce Pharma
Fri, 06/16/23 - 09:44 am
Tags:
AbbVie
,
Pharmacyclics
,
BeiGene
,
Brukinsa
,
patents
,
Imbruvica
,
blood cancer
Coherus breached Humira patent settlement by striking deal with Mark Cuban's drug firm, AbbVie contends
Fierce Pharma
Thu, 06/15/23 - 06:55 pm
Tags:
AbbVie
,
Humira
,
biosimilars
,
Mark Cuban Cost Plus Drugs
,
Coherus Biosciences
Pharma Companies, Pharmacies Agree to Pay $19B in Opioid Settlement
BioSpace
Mon, 06/12/23 - 10:15 am
Tags:
opioids
,
opioid crisis
,
legal
,
pharmacies
,
McKesson
,
AmerisourceBergen
,
Cardinal Health
,
Teva Pharmaceutical
,
AbbVie
,
JNJ
AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral
Fierce Biotech
Thu, 06/1/23 - 11:41 am
Tags:
AstraZeneca
,
IBD
,
AbbVie
,
JNJ
,
brazikumab
,
Skyrizi
,
Stelara
Mark Cuban online pharmacy to offer AbbVie Humira biosimilar
Seeking Alpha
Thu, 06/1/23 - 11:29 am
Tags:
AbbVie
,
Mark Cuban
,
Humira
,
biosimilar
,
Coherus Biosciences
,
Mark Cuban Cost Plus Drugs
,
Yusimry
AbbVie's Rinvoq passes midstage test in systemic lupus erythematosus, heads into phase 3
Fierce Pharma
Wed, 05/31/23 - 11:06 am
Tags:
AbbVie
,
Rinvoq
,
Humira
,
systemic lupus erythematosus
,
lupus
,
clinical trials
AbbVie, Genmab's lymphoma drug Epkinly snags FDA approval in heated blood cancer race
Fierce Pharma
Sun, 05/21/23 - 07:46 pm
Tags:
AbbVie
,
Genmab
,
FDA
,
anti-CD20
,
epcoritamab
,
diffuse large B-cell lymphoma
,
Epkinly
AbbVie's Rinvoq scores its 7th FDA nod, this one for Crohn's disease
Fierce Pharma
Thu, 05/18/23 - 08:36 pm
Tags:
AbbVie
,
FDA
,
Rinvoq
,
Crohn's Disease
,
Humira
Allergan's new skin-smoothing product gets FDA nod—with novel delivery mechanism
Fierce Pharma
Wed, 05/17/23 - 10:40 pm
Tags:
AbbVie
,
FDA
,
Skinvive
,
Juvederm
,
aesthetics
The waxing and waning of the speedy approval
EP Vantage
Mon, 05/15/23 - 09:58 am
Tags:
FDA
,
drug approvals
,
accelerated approvals
,
AbbVie
,
AstraZeneca
,
Bayer
,
Bristol Myers Squibb
,
JNJ
,
Merck
,
Merck KGaA
,
Novartis
,
Pfizer
2023’s biggest launches: the story so far
EP Vantage
Fri, 05/12/23 - 10:19 am
Tags:
drug launches
,
AbbVie
,
Almirall
,
Apellis Pharmaceuticals
,
Astellas
,
AstraZeneca
,
Biogen
,
CRISPR Therapeutics
,
Daiichi Sankyo
,
Eli Lilly
,
Genmab
,
GSK
,
Iveric Bio
,
Pfizer
,
Roche
,
SAGE Therapeutics
,
Sanofi
,
Sarepta Therapeutics
,
Shionogi
,
Swedish Orphan Biovitrum
,
Vertex Pharmaceuticals
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.